Sodium Phenylbutyrate Market, By Application, By Distribution Channel, By End-User, By Geography

Description

Sodium Phenylbutyrate Market is estimated to be valued at USD 2.34 Bn in 2026 and is expected to reach USD 3.73 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2.34 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.90%	2033 Value Projection:	USD 3.73 Bn

Sodium phenylbutyrate (SPB) is a notable pharmaceutical compound that has garnered significant attention in medical research and treatment approaches. As a derivative of phenylbutyric acid, SPB exhibits a wide array of therapeutic properties, making it a promising candidate for various medical conditions. Its primary application lies in the management of urea cycle disorders, a group of genetic conditions that impair the body's ability to eliminate ammonia effectively. Additionally, ongoing studies are exploring its potential for mitigating neurodegenerative diseases and cancer. This introduction aims to shed light on the essential role of sodium phenylbutyrate in advancing medical science and enhancing patient care.

Market Dynamics:

The increasing prevalence of urea cycle disorders (UCDs), growing awareness and diagnosis of rare diseases, and the expansion of orphan drug development are anticipated to drive growth of the global sodium phenylbutyrate market over the forecast period. Moreover, advancements in pharmaceutical research and development are also expected to boost the growth of the global sodium phenylbutyrate market over the forecast period. Expansion into emerging markets, development of combination therapies, expansion of indications, and increasing focus on precision medicine are expected to create growth opportunities for the global sodium phenylbutyrate market during the forecast period. The increasing prevalence of urea cycle disorders and cancer globally is driving the demand for effective treatments, which in turn is expected to boost the market growth for sodium phenylbutyrate.

However, limited awareness and underdiagnosis, high treatment costs, stringent regulatory requirements and side effects and safety concerns are expected to hamper growth of the sodium phenylbutyrate market over the forecast period.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the sodium phenylbutyrate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Horizon Therapeutics plc, Ammonett Pharma LLC, Medison Pharma Ltd., Modern Dietetics Inc., Synageva BioPharma Corp., Medison Pharma Ltd., Swedish Orphan Biovitrum AB (Sobi), Entera Health, Inc., Dipharma Francis S.r.l., Ucyclyd Pharma, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The sodium phenylbutyrate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the sodium phenylbutyrate market

Sodium Phenylbutyrate Market Detailed Segmentation:

By Application (Revenue, USD Bn, 2021 - 2033)
Pharmaceutical
Food & Beverages
Others
By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Direct Sales
Distributor Sales
Online Retail
By End User (Revenue, USD Bn, 2021 - 2033)
Hospitals and Clinics
Research Institutes
Food & Beverage Industry
Cosmetics Industry
Other Industries
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profile:
Horizon Therapeutics plc
Ammonett Pharma LLC
Medison Pharma Ltd.
Synageva BioPharma Corp.
Swedish Orphan Biovitrum AB (Sobi)
Entera Health, Inc.
Dipharma Francis S.r.l.
Ucyclyd Pharma, Inc.

Product Code: CMI6052

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Sodium Phenylbutyrate , By Application
- Market Sodium Phenylbutyrate , By Distribution Channel
- Market Sodium Phenylbutyrate , By End User
- Market Sodium Phenylbutyrate , By region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
  - Increasing prevalence of urea cycle disorders (UCDs)
- Restraints
  - Limited awareness and underdiagnosis
- Opportunities
  - Expansion into emerging markets
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Sodium Phenylbutyrate Market , By Application, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pharmaceutical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Food & Beverages
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Sodium Phenylbutyrate Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Direct Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Distributor Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Online Retail
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Sodium Phenylbutyrate Market, By End User, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Food & Beverage Industry
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Cosmetic Industry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Other Industries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Sodium Phenylbutyrate Market , By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 -2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - GCC Countries
  - Israel
  - South Africa
  - North Africa
  - Central Africa
  - Rest of Middle East

8. Competitive Landscape

Horizon Therapeutics plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ammonett Pharma LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Medison Pharma Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Synageva BioPharma Corp.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Swedish Orphan Biovitrum AB (Sobi)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Entera Health, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Dipharma Francis S.r.I.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Uncyclyd Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

9. Section

Research Methodology
About us